Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-23 11:35 AM View:  | Auchincloss Thomas G Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (48%) 34.02K to 17.63K | |
| 06-Mar-23 11:39 AM View: | Jaeger Wilfred E Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 5,125 | -- | -- | (100%) 5.13K to 0 | |
| 06-Mar-23 11:35 AM View: | Becker Marc A. Chief Financial Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 56,264 | -- | -- | (100%) 56.26K to 0 | |
| 06-Mar-23 11:33 AM View: | Aldrich Richard Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (3%) 613.38K to 596.98K | |
| 06-Mar-23 11:40 AM View: | Stuart Nancy Chief Operating Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 73,233 | -- | -- | (30%) 241.2K to 167.96K | |
| 06-Mar-23 11:33 AM View: | Aldrich Richard Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 254,877 | -- | -- | (100%) 254.88K to 0 | |
| 06-Mar-23 11:38 AM View: | Hutt Peter Barton Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (56%) 29.49K to 13.09K | |
| 06-Mar-23 11:38 AM View: | Hutt Peter Barton Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 13,088 | -- | -- | (100%) 13.09K to 0 | |
| 06-Mar-23 11:40 AM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 49,699 | -- | -- | (56%) 88.05K to 38.35K | |
| 06-Mar-23 11:41 AM View: | Tung Roger D Chief Executive Officer Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 756,427 | -- | -- | (84%) 903.96K to 147.54K | |
| 06-Mar-23 11:41 AM View: | van Heek Christi Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 25,651 | -- | -- | (100%) 25.65K to 0 | |
| 06-Mar-23 11:36 AM View: | Cassella James V Chief Development Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 57,766 | -- | -- | (42%) 138.36K to 80.59K | |
| 06-Mar-23 11:37 AM View: | Hoiland Jesper Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (76%) 21.52K to 5.13K | |
| 06-Mar-23 11:40 AM View: | Stuart Nancy Chief Operating Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 167,963 | -- | -- | (100%) 167.96K to 0 | |
| 06-Mar-23 11:39 AM View: | Jaeger Wilfred E Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (76%) 21.52K to 5.13K | |
| 06-Mar-23 11:41 AM View: | Tung Roger D Chief Executive Officer Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 57,916 | -- | -- | (6%) 961.88K to 903.96K | |
| 06-Mar-23 11:35 AM View: | Auchincloss Thomas G Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 17,625 | -- | -- | (100%) 17.63K to 0 | |
| 06-Mar-23 11:40 AM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 38,350 | -- | -- | (100%) 38.35K to 0 | |
| 06-Mar-23 11:41 AM View: | Tung Roger D Chief Executive Officer Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 147,536 | -- | -- | (100%) 147.54K to 0 | |
| 06-Mar-23 11:41 AM View: | van Heek Christi Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 16,400 | -- | -- | (39%) 42.05K to 25.65K | |
| 06-Mar-23 11:35 AM View: | Becker Marc A. Chief Financial Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 49,699 | -- | -- | (47%) 105.96K to 56.26K | |
| 06-Mar-23 11:36 AM View: | Cassella James V Chief Development Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 80,595 | -- | -- | (100%) 80.59K to 0 | |
| 06-Mar-23 11:33 AM View: | Aldrich Richard Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 342,100 | -- | -- | (57%) 596.98K to 254.88K | |
| 06-Mar-23 11:37 AM View: | Hoiland Jesper Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 5,125 | -- | -- | (100%) 5.13K to 0 | |
| 16-Feb-23 8:51 AM View: | Stuart Nancy Chief Operating Officer | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-23 | Private Sale (Planned) | 6,048 | $8.33 | $50,379.80 | (2%) 268.64K to 262.6K | |
| 16-Feb-23 8:49 AM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-23 | Private Sale (Planned) | 3,762 | $8.34 | $31,375.10 | (4%) 91.81K to 88.05K | |
| 16-Feb-23 8:48 AM View: | Cassella James V Chief Development Officer | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-23 | Private Sale (Planned) | 3,762 | $8.34 | $31,375.10 | (2%) 176.82K to 173.06K | |
| 16-Feb-23 8:47 AM View: | Becker Marc A. Chief Financial Officer | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-23 | Private Sale (Planned) | 3,762 | $8.33 | $31,337.50 | (3%) 127.63K to 123.86K | |
| 31-Jan-23 8:30 AM View: | Stuart Nancy Chief Operating Officer | Concert Pharmaceuticals, Inc. (CNCE) | 30-Jan-23 | Private Sale (Planned) | 13,200 | $8.35 | $110,220.00 | (5%) 281.84K to 268.64K | |
| 31-Jan-23 8:29 AM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 30-Jan-23 | Private Sale (Planned) | 8,493 | $8.35 | $70,916.60 | (8%) 100.3K to 91.81K | |
| 31-Jan-23 8:28 AM View: | Cassella James V Chief Development Officer | Concert Pharmaceuticals, Inc. (CNCE) | 30-Jan-23 | Private Sale (Planned) | 10,106 | $8.35 | $84,385.10 | (5%) 186.93K to 176.82K | |
| 31-Jan-23 8:27 AM View: | Becker Marc A. Chief Financial Officer | Concert Pharmaceuticals, Inc. (CNCE) | 30-Jan-23 | Private Sale (Planned) | 8,493 | $8.35 | $70,916.60 | (6%) 136.12K to 127.63K | |
| 09-Jan-23 4:18 PM View: | Tung Roger D Chief Executive Officer Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 9,240 | $7.24 | $66,897.60 | (< 1%) 1.13M to 1.12M | |
| 09-Jan-23 4:12 PM View: | Becker Marc A. Chief Financial Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 2,893 | $7.25 | $20,974.20 | (2%) 139.01K to 136.12K | |
| 09-Jan-23 4:17 PM View: | Stuart Nancy Chief Operating Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 2,893 | $7.25 | $20,974.20 | (1%) 284.74K to 281.84K | |
| 09-Jan-23 4:15 PM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 2,893 | $7.25 | $20,974.20 | (3%) 103.2K to 100.3K | |
| 09-Jan-23 4:13 PM View: | Cassella James V Chief Development Officer | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 2,893 | $7.25 | $20,974.20 | (2%) 189.82K to 186.93K | |
| 18-Oct-22 4:25 PM View: | Hutt Peter Barton Director | Concert Pharmaceuticals, Inc. (CNCE) | 14-Oct-22 | Option Sale | 3,539 | $6.09 | $21,552.50 | (11%) 33.03K to 29.49K | |
| 18-Oct-22 4:25 PM View: | Hutt Peter Barton Director | Concert Pharmaceuticals, Inc. (CNCE) | 14-Oct-22 | Option Exercise | 3,539 | $2.88 | $10,192.30 | 12% 29.49K to 33.03K | |
| 13-Jun-22 4:15 PM View: | Hutt Peter Barton Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 125% 13.09K to 29.49K | |
| 13-Jun-22 4:14 PM View: | Hoiland Jesper Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 320% 5.13K to 21.52K | |
| 13-Jun-22 4:16 PM View: | Jaeger Wilfred E Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 320% 5.13K to 21.52K | |
| 13-Jun-22 4:17 PM View: | van Heek Christi Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 64% 25.65K to 42.05K | |
| 13-Jun-22 4:13 PM View: | Auchincloss Thomas G Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 93% 17.63K to 34.02K | |
| 13-Jun-22 4:12 PM View: | Aldrich Richard Director | Concert Pharmaceuticals, Inc. (CNCE) | 09-Jun-22 | Grant | 16,400 | -- | -- | 3% 596.98K to 613.38K | |
| 06-Jun-22 5:14 PM View: | van Heek Christi Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jun-22 | Purchase | 10,526 | $4.75 | $49,998.50 | 70% 15.13K to 25.65K | |
| 06-Jun-22 5:12 PM View: | Auchincloss Thomas G Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jun-22 | Purchase | 6,000 | $4.75 | $28,500.00 | 52% 11.63K to 17.63K | |
| 06-Jun-22 5:11 PM View: | Aldrich Richard Director | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jun-22 | Purchase | 210,526 | $4.75 | $999,998.00 | 54% 386.45K to 596.98K | |
| 16-Feb-22 8:05 AM View: | Tung Roger D Chief Executive Officer Director | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-22 | Market Sale (Planned) | 13,480 | $3.09 | $41,653.20 | (1%) 1.14M to 1.13M | (9%) |
| 16-Feb-22 8:02 AM View: | Munsie Jeffrey A Chief Legal Officer | Concert Pharmaceuticals, Inc. (CNCE) | 14-Feb-22 | Market Sale (Planned) | 3,762 | $3.09 | $11,624.60 | (4%) 106.96K to 103.2K | (9%) |
